Utility of Repetitive Transcranial Stimulation as an Augmenting Treatment Method in Treatment-Resistant Depression

About 30 to 46% of patients with major depressive disorder (MDD) fail to fully respond to initial antidepressants. Treatment-resistant depression (TRD) is a severely disabling disorder with no proven treatment options; novel treatment methods like rTMS can be used as augmentation to ongoing pharmaco...

Descripción completa

Detalles Bibliográficos
Autores principales: Jhanwar, Venu Gopal, Bishnoi, R. J., Jhanwar, M. R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications 2011
Materias:
New Horizon
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195166/
https://www.ncbi.nlm.nih.gov/pubmed/22021964
http://dx.doi.org/10.4103/0253-7176.85406

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195166/
https://www.ncbi.nlm.nih.gov/pubmed/22021964
http://dx.doi.org/10.4103/0253-7176.85406

Ejemplares similares